• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

载脂蛋白 A1、卵磷脂胆固醇酰基转移酶和 PON1 的共孵育延长了高密度脂蛋白防止 LDL 氧化的时间。

Coincubation of PON1, APO A1, and LCAT increases the time HDL is able to prevent LDL oxidation.

机构信息

Division of Cardiovascular Research, University of Manchester, Oxford Road, Manchester M13 9WL, UK.

出版信息

IUBMB Life. 2012 Feb;64(2):157-61. doi: 10.1002/iub.588. Epub 2011 Dec 20.

DOI:10.1002/iub.588
PMID:22184096
Abstract

The inhibition of low-density lipoprotein (LDL) oxidation by high-density lipoprotein (HDL) is a major antiatherogenic property of this lipoprotein. This activity is due, in part, to HDL associated proteins. However, whether these proteins interact in the antioxidant activity of HDL is unknown. LDL was incubated with apolipoprotein A1 (apo A1), lecithin:cholesterol acyltransferase (LCAT), and paraoxonase-1 (PON1) alone or in combination, in the presence or absence of HDL under oxidizing conditions. LDL lipid peroxide concentrations were determined. Apo A1, LCAT, and PON1 all inhibit LDL oxidation in the absence of HDL and enhance the ability of HDL to inhibit LDL oxidation. Their effect was additive rather than synergistic; the combination of these proteins significantly enhanced the length of time LDL was protected from oxidation. This seemed to be due to the ability of PON1 to prevent the oxidative inactivation of LCAT. Apo A1, LCAT, and PON1 can all contribute to the antioxidant activity of HDL in vitro. The combination of apo A1, LCAT, and PON1 prolongs the time that HDL can prevent LDL oxidation, due, at least in part, to the prevention LCAT inactivation.

摘要

高密度脂蛋白 (HDL) 抑制低密度脂蛋白 (LDL) 氧化是该脂蛋白主要的抗动脉粥样硬化特性。这种活性部分归因于与 HDL 相关的蛋白质。然而,这些蛋白质是否在 HDL 的抗氧化活性中相互作用尚不清楚。在氧化条件下,将 LDL 与载脂蛋白 A1 (apo A1)、卵磷脂:胆固醇酰基转移酶 (LCAT) 和对氧磷酶-1 (PON1) 单独或组合孵育,存在或不存在 HDL。测定 LDL 脂质过氧化物浓度。apo A1、LCAT 和 PON1 在没有 HDL 的情况下均可抑制 LDL 氧化,并增强 HDL 抑制 LDL 氧化的能力。它们的作用是相加的,而不是协同的;这些蛋白质的组合显著延长了 LDL 免受氧化的时间。这似乎是由于 PON1 能够防止 LCAT 的氧化失活。apo A1、LCAT 和 PON1 均可在体外促进 HDL 的抗氧化活性。apo A1、LCAT 和 PON1 的组合延长了 HDL 可以防止 LDL 氧化的时间,至少部分原因是防止了 LCAT 的失活。

相似文献

1
Coincubation of PON1, APO A1, and LCAT increases the time HDL is able to prevent LDL oxidation.载脂蛋白 A1、卵磷脂胆固醇酰基转移酶和 PON1 的共孵育延长了高密度脂蛋白防止 LDL 氧化的时间。
IUBMB Life. 2012 Feb;64(2):157-61. doi: 10.1002/iub.588. Epub 2011 Dec 20.
2
Increased low-density lipoprotein oxidation and impaired high-density lipoprotein antioxidant defense are associated with increased macrophage homing and atherosclerosis in dyslipidemic obese mice: LCAT gene transfer decreases atherosclerosis.在血脂异常的肥胖小鼠中,低密度脂蛋白氧化增加和高密度脂蛋白抗氧化防御受损与巨噬细胞归巢增加及动脉粥样硬化相关:卵磷脂胆固醇酰基转移酶基因转移可减轻动脉粥样硬化。
Circulation. 2003 Apr 1;107(12):1640-6. doi: 10.1161/01.CIR.0000056523.08033.9F. Epub 2003 Mar 24.
3
A novel lecithin-cholesterol acyltransferase antioxidant activity prevents the formation of oxidized lipids during lipoprotein oxidation.一种新型卵磷脂胆固醇酰基转移酶抗氧化活性可防止脂蛋白氧化过程中氧化脂质的形成。
Biochemistry. 1999 May 11;38(19):5976-81. doi: 10.1021/bi982258w.
4
Human apolipoprotein A-II enrichment displaces paraoxonase from HDL and impairs its antioxidant properties: a new mechanism linking HDL protein composition and antiatherogenic potential.人载脂蛋白A-II的富集使对氧磷酶从高密度脂蛋白中被取代并损害其抗氧化特性:一种连接高密度脂蛋白蛋白质组成与抗动脉粥样硬化潜力的新机制。
Circ Res. 2004 Oct 15;95(8):789-97. doi: 10.1161/01.RES.0000146031.94850.5f. Epub 2004 Sep 23.
5
Oxidative inactivation of paraoxonase1, an antioxidant protein and its effect on antioxidant action.对氧磷酶1(一种抗氧化蛋白)的氧化失活及其对抗氧化作用的影响。
Free Radic Res. 2003 Dec;37(12):1319-30.
6
Atorvastatin effect on the distribution of high-density lipoprotein subfractions and human paraoxonase activity.阿托伐他汀对高密度脂蛋白亚组分分布及人对氧磷酶活性的影响。
Transl Res. 2009 Apr;153(4):190-8. doi: 10.1016/j.trsl.2009.01.007. Epub 2009 Feb 14.
7
A dual role for lecithin:cholesterol acyltransferase (EC 2.3.1.43) in lipoprotein oxidation.卵磷脂胆固醇酰基转移酶(EC 2.3.1.43)在脂蛋白氧化中的双重作用。
Free Radic Biol Med. 2007 Dec 1;43(11):1484-93. doi: 10.1016/j.freeradbiomed.2007.08.007. Epub 2007 Aug 21.
8
Effect of 3,4-dihydroxyphenylalanine on Cu(2+)-induced inactivation of HDL-associated paraoxonasel and oxidation of HDL; inactivation of paraoxonasel activity independent of HDL lipid oxidation.3,4-二羟基苯丙氨酸对铜离子(Cu(2+))诱导的高密度脂蛋白(HDL)相关对氧磷酶1失活及HDL氧化的影响;对氧磷酶1活性的失活与HDL脂质氧化无关。
Free Radic Res. 2004 Sep;38(9):969-76. doi: 10.1080/10715760400000943.
9
Minimally oxidized LDL is a potent inhibitor of lecithin:cholesterol acyltransferase activity.轻度氧化的低密度脂蛋白是卵磷脂胆固醇酰基转移酶活性的有效抑制剂。
J Lipid Res. 1996 May;37(5):1012-21.
10
ApoE induces serum paraoxonase PON1 activity and stability similar to ApoA-I.载脂蛋白 E 可诱导血清对氧磷酶 PON1 的活性和稳定性类似于载脂蛋白 A-I。
Biochemistry. 2010 Jan 26;49(3):532-8. doi: 10.1021/bi9013227.

引用本文的文献

1
High-density lipoproteins. Part 2. Impact of disease states on functionality.高密度脂蛋白。第2部分。疾病状态对功能的影响。
Am J Prev Cardiol. 2025 Aug 7;23:101073. doi: 10.1016/j.ajpc.2025.101073. eCollection 2025 Sep.
2
Human Paraoxonase 1: From Bloodstream Enzyme to Disease Fighter & Therapeutic Intervention.人对氧磷酶1:从血流中的酶到疾病抵御者及治疗干预手段
Curr Protein Pept Sci. 2025;26(4):282-295. doi: 10.2174/0113892037335325241011162207.
3
Understanding the heterogeneity and dysfunction of HDL in chronic kidney disease: insights from recent reviews.
理解慢性肾脏病中高密度脂蛋白的异质性和功能障碍:来自最新综述的见解。
BMC Nephrol. 2024 Nov 7;25(1):400. doi: 10.1186/s12882-024-03808-3.
4
Paraoxonase 1: evolution of the enzyme and of its role in protecting against atherosclerosis.对氧磷酶 1:酶的进化及其在预防动脉粥样硬化中的作用。
Curr Opin Lipidol. 2024 Aug 1;35(4):171-178. doi: 10.1097/MOL.0000000000000936. Epub 2024 Jun 18.
5
A Current Update on the Role of HDL-Based Nanomedicine in Targeting Macrophages in Cardiovascular Disease.基于高密度脂蛋白的纳米药物在心血管疾病中靶向巨噬细胞作用的最新进展
Pharmaceutics. 2023 May 15;15(5):1504. doi: 10.3390/pharmaceutics15051504.
6
Paraoxonase 1 and atherosclerosis.对氧磷酶1与动脉粥样硬化
Front Cardiovasc Med. 2023 Feb 16;10:1065967. doi: 10.3389/fcvm.2023.1065967. eCollection 2023.
7
Familial Hypercholesterolemia: Do HDL Play a Role?家族性高胆固醇血症:高密度脂蛋白发挥作用吗?
Biomedicines. 2021 Jul 13;9(7):810. doi: 10.3390/biomedicines9070810.
8
Effect of Agraz ( Swartz) on High-Density Lipoprotein Function and Inflammation in Women with Metabolic Syndrome.阿格拉兹(施瓦茨)对代谢综合征女性高密度脂蛋白功能和炎症的影响。
Antioxidants (Basel). 2018 Dec 8;7(12):185. doi: 10.3390/antiox7120185.
9
Evaluation of the prognostic value of paraoxonase 1 in the recurrence and metastasis of hepatocellular carcinoma and establishment of a liver-specific predictive model of survival.评价对氧磷酶 1 对肝癌复发转移的预测价值及建立肝癌特异性生存预测模型。
J Transl Med. 2018 Nov 26;16(1):327. doi: 10.1186/s12967-018-1707-0.
10
Dysfunctional HDL in diabetes mellitus and its role in the pathogenesis of cardiovascular disease.糖尿病患者功能失调的高密度脂蛋白及其在心血管疾病发病机制中的作用。
Mol Cell Biochem. 2018 Mar;440(1-2):167-187. doi: 10.1007/s11010-017-3165-z. Epub 2017 Aug 21.